Serum tumor necrosis factor in patients with gastric cancer

Chew Wun Wu, Chin Wen Chi, Mao Chih Hsieh, Miao Fen Chao, Wing Yiu Lui, Fang Ku P'Eng

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

We have measured serum TNF-α levels in 220 gastric cancer patients, 9 patients with gastric polyps or ulcers, 9 hepatitis B carriers and 85 normal controls. The results showed that no postitive TNF-α value ( > 10 pg/ml) was detected in Hepatitis B carriers and benign gastric lesions' patients and normal controls. In the cancer group, 17 out of 220 patients (7.7%) had positive-TNF-α values. The proportion of TNF-α positive was 6.8% in stage I disease, 6.5% in stage ll disease, 3.7% stage III, and 12.9% stage IV. No clinicopathologic factors were related to positive TNF-α value. TNF-α value was not an indenendent prognostic indicator. The role of TNF-α in gastric cancer remains obscures.

Original languageEnglish
Pages (from-to)1597-1599
Number of pages3
JournalAnticancer Research
Volume18
Issue number3 A
Publication statusPublished - May 1998

Keywords

  • Gastric cancer
  • TNF-α

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Serum tumor necrosis factor in patients with gastric cancer'. Together they form a unique fingerprint.

  • Cite this

    Wu, C. W., Chi, C. W., Hsieh, M. C., Chao, M. F., Lui, W. Y., & P'Eng, F. K. (1998). Serum tumor necrosis factor in patients with gastric cancer. Anticancer Research, 18(3 A), 1597-1599.